Cargando…

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD

BACKGROUND: There is conflicting information regarding the effects of selective and nonselective beta-blocker treatment in patients with COPD. PARTICIPANTS AND METHODS: This nested case–control study used the Taiwan National Health Insurance Research Database. We included COPD patients who used inha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yueh Lan, Lai, Chih-Cheng, Wang, Ya-Hui, Wang, Cheng-Yi, Wang, Jen-Yu, Wang, Hao-Chien, Yu, Chong-Jen, Chen, Likwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644571/ https://www.ncbi.nlm.nih.gov/pubmed/29066880 http://dx.doi.org/10.2147/COPD.S145913

Ejemplares similares

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
por: Huang, Tsan-Ming, et al.
Publicado: (2020)

Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation
por: Wang, Ya-Hui, et al.
Publicado: (2018)

The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study
por: Chen, Cheng-Hsin, et al.
Publicado: (2018)

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
por: Wang, Cheng-Yi, et al.
Publicado: (2016)

Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies
por: Hong, Shiao-Ya, et al.
Publicado: (2023)

Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022)

Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis
por: Fallahzadeh, Mohammad Amin, et al.
Publicado: (2022)

The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients
por: Zampino, Rosa, et al.
Publicado: (2018)

Fibrosis index predicts variceal bleeding and reduces need for nonselective beta-blocker in compensated cirrhosis with initial small esophageal varices without red-color sign
por: Wang, Sheng-Fu, et al.
Publicado: (2020)

Nonselective beta-blockers may lead to stage 2 acute kidney injury and waitlist mortality in child class C cirrhosis
por: Lai, Mason, et al.
Publicado: (2023)

The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018)

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography
por: McDonald, Natasha, et al.
Publicado: (2017)

Nonselective Beta-Blockers for the Efficacious Healing of Ulcerated Infantile Hemangiomas in Unusual Locations of Two Female Infants
por: Poulose, Divya, et al.
Publicado: (2021)

Nonselective beta-adrenoceptor blocker use and risk of Parkinson’s disease: from multiple real-world evidence
por: Feng, Zeying, et al.
Publicado: (2023)

Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
por: Cheng, Shih-Lung, et al.
Publicado: (2021)

Carvedilol Versus Other Nonselective Beta Blockers for Variceal Bleeding Prophylaxis and Death: A Network Meta-analysis
por: Cheung, Ka-Shing, et al.
Publicado: (2023)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017)

Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
por: Ferrarese, Alberto, et al.
Publicado: (2018)

Is there any vindication for low dose nonselective β-blocker medication in patients with liver cirrhosis?
por: Kim, Tae Wan, et al.
Publicado: (2012)

The association between COPD and outcomes of patients with advanced chronic kidney disease
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis
por: Mao, Gang, et al.
Publicado: (2022)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
por: Chen, Shih-Yu, et al.
Publicado: (2021)

Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies
por: Du, Qingxia, et al.
Publicado: (2014)

Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017)

An evaluation of the effects of nonselective and cardioselective β-blockers on wound healing in Sprague Dawley rats
por: Raut, Sanket B., et al.
Publicado: (2012)

Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
por: Lin, Shan-Ju, et al.
Publicado: (2023)

Impact of Nonselective and Selective α−1 Adrenergic Blockers on the Sedative Efficacy of Dexmedetomidine in Urologic Surgery: A Prospective, Observational Study
por: Baik, Jiseok, et al.
Publicado: (2023)

Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case–Control Cohort Study
por: Chou, Chia-I., et al.
Publicado: (2016)

β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
por: Chang, Catherina L., et al.
Publicado: (2017)

Nonselective β-blocker propranolol for orbital and periorbital hemangiomas in infants: a new first-line of treatment?
por: El-Essawy, Rania, et al.
Publicado: (2011)

Retracted: Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis
por: International, BioMed Research
Publicado: (2023)

COPD in Taiwan: a National Epidemiology Survey
por: Cheng, Shih-Lung, et al.
Publicado: (2015)

Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K(V)10.1 Pore Blockers
por: Toplak, Žan, et al.
Publicado: (2021)

An Overview of the CNS-Pharmacodynamic Profiles of Nonselective and Selective GABA Agonists
por: Chen, Xia, et al.
Publicado: (2012)

Structural plasticity of the selectivity filter in a nonselective ion channel
por: Roy, Raktim N., et al.
Publicado: (2021)

Who's Afraid of the Big Bad Wolf? Safety of Beta-Blockers in COPD
por: Ambrosio, Giuseppe, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_869vjb946s12cqj3pm32t1c5ge